The above picture is of Dr. Jayakumar Rajadas's team at Stanford. This is the team that discovered Disulfiram eradicated Lyme in 2016 with a high through put screen study (shared on the publications page). Since then the hype has increased a great deal. Continued support of the research team is necessary to bring a safer delivery to Lyme patients in a reformulation. This lab is stellar and dedicating 100% of it's efforts now to curing Lyme disease. The patient community is elated after having no effective treatment to date that is as affordable as disulfiram that is also broad spectrum. Thank you to Stanford University and the Rajadas Lyme team at BioADD for your continued efforts!!
-Dr. Kenneth B. Liegner, Pioneer doctor who started using disulfiram first in Lyme patients. He is a hero among the medical community and goes above and beyond for his patients! His publications and interview is on this site under the respective tabs. Thank you Dr. Liegner!
-Dr. Dan Kinderlehrer is treating over 100 Lyme disease patients with disulfiram. He calls it a "game changer" in treating Lyme that has been so complex and difficult to treat in the passed. His publications and interview is on this site under the respective tabs. Thank you Dr. Kinderlehrer!
-Dr. Kim Lewis of Northeastern University has been funded by the Cohen's and is studying disulfiram. If it weren't for his initial study on persister cells, we'd never have gotten to initiate the search for treatment for persistent Lyme complex. We anticipate the release of the articles on his work in which I will post on this site.
-Dr. Monica Embers is an Assistant Professor in the Division of Bacteriology and Parasitology at Tulane University. She has been funded by Bay Area Lyme Foundation to study disulfiram in mice. I'll share more when she releases her information.
Need a doctor for Disulfiram? Email Kristina below. We only recommend working with a medical professional while undergoing Lyme treatment with disulfiram. It's important to check labs and monitor your well being.